**Pregnancy**

Teratogenicity with leflunomide contraindicates its use during pregnancy and warrants discretion in females during childbearing years.

**Liver impairment**

Leflunomide is contraindicated in severe hepatic impairment due to hepatotoxicity.

**Lung Disease**

Leflunomide is also contraindicated in patients with underlying Interstitial lung disease and can cause symptoms within three months of starting leflunomide.

Other contraindications include hypersensitivity, previous or current skin reactions, immunosuppression, and impaired bone marrow function.